# Prolactina - Homens: Enrichment Quick Summary

## Status: âœ… COMPLETE

**Score Item ID:** `3bf4ce1f-c278-495a-90af-27e84cf9463b`
**Execution Date:** 2026-01-29
**Execution Time:** ~2 minutes

---

## What Was Done

### 1. Content Enrichment âœ…
- **Clinical Relevance:** 1,289 characters - Evidence-based interpretation for healthcare professionals
- **Patient Explanation:** 1,044 characters - Clear, accessible language for patients
- **Conduct Guidelines:** 1,790 characters - Structured clinical decision support by severity level
- **Last Review:** Updated to current timestamp

### 2. Scientific Articles âœ…
Added 4 peer-reviewed articles (2023-2024):

| Journal | Year | Type | Focus |
|---------|------|------|-------|
| Frontiers in Endocrinology | 2024 | Review | Male-specific prolactinoma differences |
| PLOS ONE | 2024 | Research | Hyperprolactinemia with normal testosterone |
| Journal of Endocrine Society | 2024 | Research | Eugonadal men with prolactinomas |
| Int J Impotence Research | 2023 | Meta-analysis | Sexual dysfunction and hyperprolactinemia |

### 3. Database Links âœ…
- Properly linked all articles to score item via `article_score_items` junction table
- Foreign key integrity maintained
- Total of 13 articles now linked (4 new + 9 existing MFI lectures)

---

## Key Clinical Insights

1. **Male-Specific Pattern:** Prolactinomas in men tend to be larger, more invasive, with higher prolactin levels at diagnosis
2. **Prevalence:** 2-4% of men with erectile dysfunction have hyperprolactinemia
3. **Dual Mechanism:** Prolactin affects sexual function both through testosterone suppression AND direct erectile pathway effects
4. **Treatment Success:** Cabergoline normalizes prolactin in 80-90% of cases
5. **Clinical Pearl:** ~10% of men with high prolactin have normal testosterone but still benefit from treatment

---

## Reference Ranges (from enrichment)

- **Normal:** <15-20 ng/mL (<318-425 mUI/L)
- **Mildly Elevated:** 20-50 ng/mL (repeat, investigate causes)
- **Moderately Elevated:** 50-100 ng/mL (MRI + endocrinology referral)
- **Severely Elevated:** >100 ng/mL (probable prolactinoma, urgent referral)

---

## Verification Results

```
Score Item: Prolactina - Homens
â”œâ”€ Clinical Relevance: 1,289 chars âœ…
â”œâ”€ Patient Explanation: 1,044 chars âœ…
â”œâ”€ Conduct Guidelines: 1,790 chars âœ…
â”œâ”€ Last Review: 2026-01-29 âœ…
â””â”€ Linked Articles: 13 total (4 new scientific + 9 MFI lectures) âœ…
```

---

## Files Created

1. `/home/user/plenya/scripts/enrich_prolactina_homens.sql` - Complete enrichment script
2. `/home/user/plenya/PROLACTINA-HOMENS-ENRICHMENT-REPORT.md` - Detailed report (3,000+ words)
3. `/home/user/plenya/PROLACTINA-HOMENS-QUICK-SUMMARY.md` - This quick reference

---

## Database Commands Used

```sql
-- Update score item
UPDATE score_items SET clinical_relevance = '...', patient_explanation = '...', conduct = '...', last_review = CURRENT_TIMESTAMP WHERE id = '3bf4ce1f-c278-495a-90af-27e84cf9463b';

-- Insert 4 articles
INSERT INTO articles (...) VALUES (...);

-- Link articles to score item
INSERT INTO article_score_items (score_item_id, article_id) SELECT ...;
```

All executed successfully with transaction integrity maintained.

---

## Next Steps (If Desired)

1. Enrich related hormonal markers (Testosterone, LH, FSH)
2. Create hormone panel groupings
3. Add imaging interpretation guidelines
4. Develop treatment algorithm flowcharts

---

**Methodology:** Evidence-based enrichment following Plenya EMR best practices
**Quality:** All content derived from peer-reviewed literature (2023-2024)
**Schema Compliance:** âœ… Correct tables and relationships used
**Ready for Production:** âœ… Yes

---

**Report Generated:** 2026-01-29
**Status:** ðŸŽ‰ Successfully Completed
